The main asymmetric complete synthesis of conolidine was developed by Micalizio and coworkers in 2011.[2] This synthetic route enables access to both enantiomer (mirror picture) of conolidine via an early enzymatic resolution. "We confirmed that conolidine binds to the recently recognized opioid receptor ACKR3, even though exhibiting no affinity https://jimia157sqs9.wikijournalist.com/user